Back to all bills
S 822119th CongressIntroduced
Scientific EXPERT Act of 2025
Introduced: Oct 29, 2025
Standard Summary
Comprehensive overview in 1-2 paragraphs
The Scientific EXPERT Act establishes a process for science-focused drug development meetings led by the Reagan-Udall Foundation to facilitate development of treatments for rare diseases.
Key Points
- 1Creates EL-SFDD meetings for rare disease drug development discussions
- 2Establishes permanent multistakeholder steering committee
- 3Requires minimum of 4 meetings annually focusing on different rare diseases
- 4Mandates FDA review division participation in meetings
- 5Requires public availability of meeting transcripts and summaries
- 6Includes annual reporting and evaluation requirements
Impact Areas
Rare disease patients and advocacy groupsPharmaceutical companies developing rare disease treatmentsFDA regulatory processesAcademic researchers and medical expertsReagan-Udall Foundation
Generated by kwaipilot/kat-coder-pro:free on Nov 19, 2025